Q3 FY2024 Earnings
Financial report interval: 2024.06.30 - 2024.09.30
Overview: Cyclo Therapeutics(CYTH) the Revenue is 233.77 K (-52.82%);the EBIT is -8.289 M (-73.88%);the EPS is -0.307 (-4.33%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B52.82%
----
----
EBIT
-0.01B73.88%
----
----
EPS
-0.30754.33%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf